Innolign Biomedical develops novel assays to study human physiology and disease for the purpose of accelerating the discovery and development of new therapeutics. We have leveraged our expertise in tissue engineering, cell biology and microdevice design to develop platform technologies for engineering miniature biomimetic "organs on a chip." To date, we have successfully worked with several industry clients to implement our device technologies for use in their drug discovery programs. Click the link below to learn more about our technology and service offerings.
Innolign's platform technologies enable us to design contractile microtissues that recapitulate the complex architecture and biomechanical function of native human tissues such as cardiac and skeletal muscle. Our technology is highly customizable to the specific requirements and aims of clients. To find out if our technology platform can help you in your specific application, please contact us using the form below.